潜水简报:
The Kerry Group, a global taste and nutrition company based in Tralee, Ireland,announced in a company statementthat it is acquiring Ohio-based Ganeden Inc., a developer and manufacturer of probiotics. The terms were not disclosed.
According to Food NavigatorKerry首席执行官Edmund Scanlon告诉投资者，Ganeden发布了当年收入约为2500万美元，并在补充剂，食品，饮料，营养和个人护理市场中拥有超过135项技术专利。
The company's statement said that it expects the Ganeden purchase to complement its2015年收购well从Biothera药品。wellproduces an immune-enhancing yeast product used in foods, beverages and supplements.
潜入洞察力：
Kerry has收购了其他几家美国公司in recent years. In 2015, along with Wellmune, the company bought Massachusetts-based Island Oasis, a supplier of beverages and equipment to the hospitality sector. It also bought Wisconsin-based Red Arrow Products, a supplier of smoke flavorings for meat, in adeal worth $735 million。2014年，克里买了Wynnstarr Flavors和Kfi Savory, the U.S.-based savory business of Kraft Food Ingredients. In 2011, it completed the acquisition ofCargill Flavor Systems售价2.3亿美元。
Kerry随着这个收购Ganeden正在向健康和健康竞技场移动。其最着名的产品是一种可选择益生菌的专利毒性细菌，叫GanedenBC30，以及它recently announced a newinactivated probiotic called Staimune, which the company said has similar immune boosting and anti-inflammatory benefits.
益生菌公司生产一种可以进入许多食物和饮料的菌株，很好地将增加的价值带到其新所有者。Ganeden总裁兼首席执行官Michael Bushrecently told Food Dive该公司已“基本上发明了这个市场空间”，并且每隔几年都在增加了一倍。
"We have done a lot of work. We were the first one into baking mixes and probiotic waters and juices and protein powders. We have so many firsts, it's hard to name them," he said.
To cash in on the益生菌热潮，制造商已经开始购买益生菌公司或将您的良好细菌添加到各种产品中。百事可乐acquired probiotics beverage maker凯夫塔。Earlier this year, itlaunched its Tropicana Essentials Probiotics line。And 301 INC, the venture capital unit of General Mills. led a $6.5-million Series D investment round in March tobenefit Farmhouse Culture，发酵和益生菌食品和饮料启动。
全球益生菌市场reached $34 billion in sales in 2015, according to a report from BCC Research. The food and beverage industry accounted for 73%, or $24.8 billion, of that market. Globally, the probiotics market is expected to grow at a CAGR of about 7.3% during the next 10 years, to reach a value of about $74.7 billion by 2025.
Clearly the Kerry Group knows what it's doing by snapping up Ganeden at this stage of the game. It not only gains a larger foothold in the health and wellness sector, but, after working through the costs and operational changes associated with integration, will be better positioned to take advantage of developments in the ever-expanding probiotics and functional foods markets.
